Pravastatin
Pravastatin, sold under the brand name Pravachol among others, is a statin medication, used for preventing cardiovascular disease in those at high risk and treating abnormal lipids. It is suggested to be used together with diet changes, exercise, and weight loss. It is taken by mouth.
Clinical data | |
---|---|
Trade names | Pravachol, Selektine, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a692025 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 18% |
Protein binding | 50% |
Metabolism | Liver (minimal) |
Elimination half-life | 1-3 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.216.225 |
Chemical and physical data | |
Formula | C23H36O7 |
Molar mass | 424.534 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Common side effects include joint pain, diarrhea, nausea, headaches, and muscle pains. Serious side effects may include rhabdomyolysis, liver problems, and diabetes. Use during pregnancy may harm the fetus. Like all statins, pravastatin works by inhibiting HMG-CoA reductase, an enzyme found in liver that plays a role in producing cholesterol.
Pravastatin was patented in 1980 and approved for medical use in 1989. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2021, it was the 39th most commonly prescribed medication in the United States, with more than 15 million prescriptions.